Compare SON & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SON | TMDX |
|---|---|---|
| Founded | 1899 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 3.8B |
| IPO Year | 2014 | 2019 |
| Metric | SON | TMDX |
|---|---|---|
| Price | $51.52 | $67.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $60.13 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | ★ 510.30 | 382.18 |
| EPS | ★ 0.68 | 0.20 |
| Revenue | ★ $7,518,753,000.00 | $605,494,000.00 |
| Revenue This Year | $0.10 | $24.25 |
| Revenue Next Year | $1.82 | $18.75 |
| P/E Ratio | ★ $76.29 | $362.75 |
| Revenue Growth | ★ 41.72 | 37.13 |
| 52 Week Low | $38.65 | $70.00 |
| 52 Week High | $58.44 | $156.00 |
| Indicator | SON | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 47.96 | 19.80 |
| Support Level | $50.96 | N/A |
| Resistance Level | $58.14 | $131.86 |
| Average True Range (ATR) | 1.83 | 5.31 |
| MACD | 0.09 | -3.88 |
| Stochastic Oscillator | 47.28 | 0.17 |
Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.